5 min listen
Prasad Kulkarni on dengue monoclonal antibodies
Prasad Kulkarni on dengue monoclonal antibodies
ratings:
Length:
19 minutes
Released:
Feb 23, 2024
Format:
Podcast episode
Description
Prasad Kulkarni discusses a new Phase I trial in The Lancet Infectious Diseases on a dengue monoclonal antibody also known as VIS513 in healthy adults. In addition, he highlights the wider implications of this for dengue control and drug development.Read the full article:https://www.thelancet.com/journals/laninf/article/ S1473-3099(24)00030-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_laninfContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
Released:
Feb 23, 2024
Format:
Podcast episode
Titles in the series (100)
The Lancet Infectious Diseases: October 01, 2007 by The Lancet Infectious Diseases in conversation with